Literature DB >> 9874200

Structural organization and chromosomal localization of the human hepatocyte growth factor activator gene--phylogenetic and functional relationship with blood coagulation factor XII, urokinase, and tissue-type plasminogen activator.

K Miyazawa1, Y Wang, S Minoshima, N Shimizu, N Kitamura.   

Abstract

The organization and structure of the gene coding for hepatocyte growth factor activator (HGFA) have been determined by isolation of unique clones from a human genomic library. These clones were characterized by restriction mapping, Southern blotting and DNA sequencing. The complete sequence of the gene was determined and found to span about 7.5 kilobases of DNA and consist of 14 exons separated by 13 introns. The coding region of HGFA consists of multiple putative domains that are homologous to those observed in blood coagulation factor XII (FXII). These regions were found as separate exons in the gene, and the exon/intron arrangement was similar to that of FXII, suggesting that the genes for HGFA and FXII have arisen through gene duplication events from a common ancestral gene. The major transcription initiation site is located 75 bp upstream of the translational start codon. The gene was mapped to chromosome 4p16, using spot-blot hybridization on sorted chromosomes and fluorescence in situ hybridization on metaphase chromosome spreads. The phylogenetic and functional relationships between HGFA and FXII as well as urokinase and tissue-type plasminogen activator are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874200     DOI: 10.1046/j.1432-1327.1998.2580355.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Molecular markers of serine protease evolution.

Authors:  M M Krem; E Di Cera
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

2.  Integrin alpha6 cleavage: a novel modification to modulate cell migration.

Authors:  Sangita C Pawar; Manolis C Demetriou; Raymond B Nagle; G Tim Bowden; Anne E Cress
Journal:  Exp Cell Res       Date:  2007-01-17       Impact factor: 3.905

Review 3.  Single-chain factor XII: a new form of activated factor XII.

Authors:  Ivan Ivanov; Anton Matafonov; David Gailani
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

4.  Integrin A6 Cleavage in Mouse Skin Tumors.

Authors:  Manolis C Demetriou; Kevin A Kwei; Marianne B Powell; Raymond B Nagle; G Tim Bowden; Anne E Cress
Journal:  Open Cancer J       Date:  2008-01-01

Review 5.  Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.

Authors:  Hiroshi Itoh; Hiroaki Kataoka
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

6.  Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.

Authors:  Manolis C Demetriou; Michael E Pennington; Raymond B Nagle; Anne E Cress
Journal:  Exp Cell Res       Date:  2004-04-01       Impact factor: 3.905

7.  Coagulation factor XII protease domain crystal structure.

Authors:  M Pathak; P Wilmann; J Awford; C Li; B K Hamad; P M Fischer; I Dreveny; L V Dekker; J Emsley
Journal:  J Thromb Haemost       Date:  2015-03-11       Impact factor: 5.824

8.  Origin and diversification of the plasminogen activation system among chordates.

Authors:  Andrés Chana-Muñoz; Agnieszka Jendroszek; Malene Sønnichsen; Tobias Wang; Michael Ploug; Jan K Jensen; Peter A Andreasen; Christian Bendixen; Frank Panitz
Journal:  BMC Evol Biol       Date:  2019-01-17       Impact factor: 3.260

Review 9.  Role of cancer cell-stroma interaction in invasive growth of cancer cells.

Authors:  Hiroaki Kataoka; Hiroyuki Tanaka; Koki Nagaike; Shuichiro Uchiyama; Hiroshi Itoh
Journal:  Hum Cell       Date:  2003-03       Impact factor: 4.374

Review 10.  Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair.

Authors:  Tsuyoshi Fukushima; Shuichiro Uchiyama; Hiroyuki Tanaka; Hiroaki Kataoka
Journal:  Int J Mol Sci       Date:  2018-11-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.